Ryan J. Taft, PhD, is Director, Scientific Research at Illumina Inc., with a focus on the development and deployment of diagnostic whole genome sequencing worldwide, particularly for patients with rare and undiagnosed genetic disease. He leads a team within the Center for Population and Medical Genomics that includes the Illumina Clinical Services Laboratory (a CLIA- CAP provider of whole genome sequencing).
Previously, Dr. Taft was a Group Leader & Senior Research Fellow at the University of Queensland, where he still holds a partial appointment, and is Adjunct Associate Professor at the George Washington University School of Medicine and Health Sciences. He has published in a variety of well-regarded journals – including articles in Nature Genetics, Nature Structural and Molecular Biology, the American Journal of Human Genetics, and others.
Dr. Taft holds various positions within industry organizations. Specifically, he is a founding member of the Global Leukodystrophy Initiative; scientific advisor of the Mission Massimo Foundation; founder and organizer of the Queensland Area RNA Club; and a member of the medical and scientific advisory board of Global Genes.
He obtained his Bachelor of Science in Biochemistry and Molecular Biology from the University of California, Davis on a Regent’s Scholarship, and his PhD in Genomics and Computational Biology from the University of Queensland on a US National Science Foundation Research Fellowship.